These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17112636)

  • 1. Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain.
    Creeley CE; Wozniak DF; Nardi A; Farber NB; Olney JW
    Neurobiol Aging; 2008 Feb; 29(2):153-67. PubMed ID: 17112636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of donepezil and memantine for protective effect against amyloid-beta(1-42) toxicity in rat septal neurons.
    Kimura M; Komatsu H; Ogura H; Sawada K
    Neurosci Lett; 2005 Dec; 391(1-2):17-21. PubMed ID: 16154269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
    Woodruff-Pak DS; Tobia MJ; Jiao X; Beck KD; Servatius RJ
    Neuropsychopharmacology; 2007 Jun; 32(6):1284-94. PubMed ID: 17119537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use.
    Wenk GL; Quack G; Moebius HJ; Danysz W
    Life Sci; 2000 Feb; 66(12):1079-83. PubMed ID: 10737358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of memantine for the treatment of dementia.
    Lo D; Grossberg GT
    Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial].
    Hu HT; Zhang ZX; Yao JL; Yu HZ; Wang YH; Tang HC; Ji CJ; Xu T
    Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):277-80. PubMed ID: 16780671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of memantine for the treatment of Alzheimer's disease.
    Matsunaga S; Kishi T; Nomura I; Sakuma K; Okuya M; Ikuta T; Iwata N
    Expert Opin Drug Saf; 2018 Oct; 17(10):1053-1061. PubMed ID: 30222469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.
    Deardorff WJ; Grossberg GT
    Drug Des Devel Ther; 2016; 10():3267-3279. PubMed ID: 27757016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Yuede CM; Coughlan C; Lewis B; Csernansky JG
    Neuropsychopharmacology; 2008 Dec; 33(13):3226-36. PubMed ID: 18418360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil.
    Periclou AP; Ventura D; Sherman T; Rao N; Abramowitz WT
    Ann Pharmacother; 2004 Sep; 38(9):1389-94. PubMed ID: 15266045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: A possible role of nNOS and combined effects with donepezil.
    Ota H; Ogawa S; Ouchi Y; Akishita M
    Exp Gerontol; 2015 Dec; 72():109-16. PubMed ID: 26408226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.
    Owen RT
    Drugs Today (Barc); 2016 Apr; 52(4):239-48. PubMed ID: 27252988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
    Repantis D; Laisney O; Heuser I
    Pharmacol Res; 2010 Jun; 61(6):473-81. PubMed ID: 20193764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
    Enz A; Gentsch C
    Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice.
    Yabuki Y; Matsuo K; Hirano K; Shinoda Y; Moriguchi S; Fukunaga K
    Pharmacology; 2017; 99(3-4):160-171. PubMed ID: 28049192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.
    Zaja-Milatovic S; Gupta RC; Aschner M; Milatovic D
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):124-31. PubMed ID: 19615394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.